Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury.
Saved in:
| Title: | Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury. |
|---|---|
| Authors: | Jang H; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea., Shin D; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea., Park B; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea., Lee JH; Department of Applied Life Science, BK21 Program, Konkuk University, Chungju, Republic of Korea., Ryu Y; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea., Lee J; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea., Ko E; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea., Ko YS; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Lee HY; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Choi YE; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Oh SW; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Jo SK; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea., Lee S; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea., Park J; Department of Applied Life Science, BK21 Program, Konkuk University, Chungju, Republic of Korea., Kim K; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Kim SH; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea. sunkim@kist.re.kr.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. sunkim@kist.re.kr., Kim MG; Division of Nephrology, Department of Internal Medicine, Korea University Medical College, Seoul, Republic of Korea. gyu219@hanmail.net., Yang Y; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea. yangys@skku.edu., Shim MK; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. mks@kist.re.kr. |
| Source: | Journal of nanobiotechnology [J Nanobiotechnology] 2026 Apr 10; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
